Filing excerpt
The segment’s operating margin was favorably impacted by the Exosome Diagnostics divestiture and ongoing profitability initiatives, partially offset by unfavorable product mix.
Source: Autobound Signal API · 80 signals tracked for Bio-Techne · updated
Get Bio-Techne's live signals in Claude or ChatGPT, or by API
What changed at Bio-Techne this week? Use Autobound signals for bio-techne.com.Bio-Techne reported operating margin improvements in its Diagnostics and Spatial Biology segment driven in part by the Exosome Diagnostics divestiture.
Filing excerpt
The segment’s operating margin was favorably impacted by the Exosome Diagnostics divestiture and ongoing profitability initiatives, partially offset by unfavorable product mix.
What this signalsFilings often name leadership changes, deals and spending plans.
sec-10qdivestitureGet every 10-Q signal for Bio-Techne and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Bio-Techne this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/74eb8674-c4c4-43e7-8409-6f47d8d978ef returns this record as JSON. POST /v1/companies/enrich returns every signal for bio-techne.com.
{
"signal_id": "74eb8674-c4c4-43e7-8409-6f47d8d978ef",
"signal_type": "sec-10q",
"signal_subtype": "divestiture",
"detected_at": "2026-11-09T06:27:08.549+00:00",
"company": {
"name": "Bio-Techne",
"domain": "bio-techne.com"
},
"data": {
"detail": "Bio-Techne reported operating margin improvements in its Diagnostics and Spatial Biology segment driven in part by the Exosome Diagnostics divestiture. Teams targeting carved-out or streamlined operational units may find new integration or workflow modernization opportunities.",
"metrics": {
"timeframe": "current_quarter"
},
"quarter": "Q3",
"summary": "Diagnostics and Spatial Biology operating margin benefited from Exosome Diagnostics divestiture",
"excerpts": "The segment’s operating margin was favorably impacted by the Exosome Diagnostics divestiture and ongoing profitability initiatives, partially offset by unfavorable product mix.",
"relevance": 0.75,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/842023/000110465926056302/tech-20260331x10q.htm",
"filing_date": "2026-05-06",
"filing_year": 2026,
"fiscal_year": 2026,
"period_end_date": "2026-03-31",
"sales_relevance": "Carve-out support needed",
"signal_category": "strategic"
}
}
curl https://signals.autobound.ai/v1/signals/74eb8674-c4c4-43e7-8409-6f47d8d978ef \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"bio-techne.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.